Al Hammadi Holding Company, a healthcare group, provides healthcare services in the Kingdom of Saudi Arabia. The company was founded in 1985 and is based in Riyadh. The company operates through Medical Services and Pharmaceuticals Products segments. The group manages two state-of-the-art hospitals, offering a combined capacity of 600 inpatient rooms and 180 outpatient clinics, with a workforce ranging from 1,000 to 5,000 employees.
The company reported revenue of $304.7M, demonstrating substantial market presence in the Saudi healthcare sector. The company changed its name to Al Hammadi Holding Company in August 2022, formerly known as Al Hammadi Company For Development and Investment. The company obtained Capital Market Authority approval to increase its capital to 750 million Saudi Riyals through an Initial Public Offering on July 15, 2014, listed on the Saudi Financial Market (Tadawul).
The Company's subsidiaries include Medical Support Services Company Limited, Pharmaceutical Services Company Limited, and Medical Industries Company Limited. In line with the Group's ambitious growth plans and the Saudi Vision 2030 strategy, Al Hammadi is aiming to inaugurate two more facilities in Riyadh over the coming six years, more than doubling its inpatient and outpatient capacity.
Facts compiled by Executive Moves from publicly available news and press releases on 12 September 2026. Spotted an inaccuracy? Email us and we'll review within 1 business day.
To upgrade to a Premium Profile reach out to us at info@executive-moves.com.
Are you on the Al Hammadi Holding Company team?
This is a Light company page, auto-generated from public news coverage. Claim it to verify the company description, add logo and links, and control how your organisation is represented on Executive Moves.
Claim this company →
